Bayesian Capital Management’s Chemed CHE Stock Holding History

Bayesian Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,904	Closed	-$929K	–	532
2019 Q1	$929K	Buy	2,904 +208	+8%	+$63.9K	0.18%	164
2018 Q4	$764K	Buy	+2,696	New	+$814K	0.16%	204
2018 Q3	–	Sell	-1,219	Closed	-$392K	–	642
2018 Q2	$392K	Buy	+1,219	New	+$381K	0.09%	328
2018 Q1	–	Sell	-1,163	Closed	-$283K	–	607
2017 Q4	$283K	Buy	+1,163	New	+$264K	0.06%	425

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bayesian Capital Management's CHE Position: Q2 2019 in Review

Bayesian Capital Management sold out of Chemed (CHE) in Q2 2019, closing a stake of 2,904 shares — an estimated $929K sold.

Bayesian Capital Management first reported a position in CHE in Q4 2017 and held it in 4 quarters. The position peaked at $929K in Q1 2019. 370 funds tracked by Wall St. Rank hold CHE as of Q2 2019.

Bayesian Capital Management reported no remaining Chemed position as of Q2 2019 after selling out during the quarter.
Bayesian Capital Management sold 2,904 Chemed shares in Q2 2019, an estimated $929K.
Bayesian Capital Management first reported a position in Chemed in Q4 2017 and held it in 4 quarters.
Bayesian Capital Management's Chemed position peaked at $929K in Q1 2019.
370 funds tracked by Wall St. Rank held Chemed as of Q2 2019.

Based on Bayesian Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.